| 1 | modalities | 3,768 |
| 2 | modality | 2,784 |
| 3 | latae | 15 |
| 4 | abacavir-lamivudine-zidovudine | 13 |
| 5 | aggressors | 9 |
| 6 | ebus/eus | 4 |
| 7 | fluoxetine/cbt | 4 |
| 8 | irradiation-heat | 4 |
| 9 | ppc/pobh | 4 |
| 10 | trabeculotomy-trabeculectomy | 4 |
| 11 | fs/te | 3 |
| 12 | heat-irradiation | 3 |
| 13 | ultrasound-biochemistry | 3 |
| 14 | dc/ah | 2 |
| 15 | dexmedetomidine/fentanyl | 2 |
| 16 | estradiol-levonorgestrel | 2 |
| 17 | glizigen-viusid | 2 |
| 18 | hypercholesterolemia-hypertriglyceridemia | 2 |
| 19 | pentoxifylline-tocopherol | 2 |
| 20 | progestogen-estrogen | 2 |
| 21 | psycho-pharmacotherapy | 2 |
| 22 | seasonal-pandemic | 2 |
| 23 | simulation- | 2 |
| 24 | vasopressin-epinephrine | 2 |
| 25 | 2-arylethynyl-n | 1 |
| 26 | 5-fluorouracil+adriamycin | 1 |
| 27 | abnormalities-edema | 1 |
| 28 | abnormlities | 1 |
| 29 | alpha/beta-blockade | 1 |
| 30 | alpha/beta-blocker | 1 |
| 31 | alpha1-beta-blockade | 1 |
| 32 | antibiotic/corticosteroid | 1 |
| 33 | antidepressant/psychotherapy | 1 |
| 34 | antimuscarinic+α-blocker | 1 |
| 35 | anxiolytic-antidepressant | 1 |
| 36 | arvs/ei-aeds | 1 |
| 37 | arvs/nei-aeds | 1 |
| 38 | asa-statin | 1 |
| 39 | at/rt/imt | 1 |
| 40 | benzodiazepines/antipsychotics | 1 |
| 41 | beta-blocker-diuretic | 1 |
| 42 | bsph/masters | 1 |
| 43 | c2-phenylethynyl | 1 |
| 44 | cbt-antidepressant | 1 |
| 45 | clearpath | 1 |
| 46 | cm-mtssg | 1 |
| 47 | cognitive/performance | 1 |
| 48 | counseling- | 1 |
| 49 | ct-pharmacotherapy | 1 |
| 50 | delignification-il | 1 |
| 51 | dexamethasone-suppression/crh-stimulation | 1 |
| 52 | doxycycline-gentamicin | 1 |
| 53 | doxycycline/co-trimoxazole | 1 |
| 54 | ebrt/bt | 1 |
| 55 | effects.amoxicillin | 1 |
| 56 | end-variables | 1 |
| 57 | eood | 1 |
| 58 | erosion/abrasion | 1 |
| 59 | estrogen/progestogen- | 1 |
| 60 | exp/rp-dcs | 1 |
| 61 | findings-individually | 1 |
| 62 | flcκ+flcλ | 1 |
| 63 | flowcytobot | 1 |
| 64 | fluconazole/amphotericin-b | 1 |
| 65 | fluoride-laser | 1 |
| 66 | fluoxetine-tricyclic | 1 |
| 67 | fnb-pi | 1 |
| 68 | fnb-snb | 1 |
| 69 | freeze- | 1 |
| 70 | furosemide/spironolactone | 1 |
| 71 | g308a | 1 |
| 72 | gemfibrozil/diet | 1 |
| 73 | heat/ultrasonication | 1 |
| 74 | hypolipidaemia | 1 |
| 75 | i.v./i.a | 1 |
| 76 | icp/cpp- | 1 |
| 77 | intrasaccular | 1 |
| 78 | intravenous-intraperitoneal | 1 |
| 79 | laser-fluoride | 1 |
| 80 | laser/fluoride | 1 |
| 81 | me-ketamine | 1 |
| 82 | measurement-förster | 1 |
| 83 | mesoscopic-network | 1 |
| 84 | metformin/pioglitazone | 1 |
| 85 | methotrexate/sulphasalazine/hydroxychlorquine | 1 |
| 86 | methylphenidate-quetiapine | 1 |
| 87 | methylphenidate/behavioural | 1 |
| 88 | mevinolin-neomycin | 1 |
| 89 | mgb1d-and | 1 |
| 90 | micromechanics | 1 |
| 91 | modalities-ultrasound | 1 |
| 92 | modem-interface | 1 |
| 93 | naa-based | 1 |
| 94 | noradrenaline/serotonin | 1 |
| 95 | nrt/hp | 1 |
| 96 | oi/eds | 1 |
| 97 | p=2.4×10 | 1 |
| 98 | pacap6-38- | 1 |
| 99 | peer-expert | 1 |
| 100 | ph-potentiometric | 1 |
| 101 | pharmaco-psychotherapy | 1 |
| 102 | pharmacotherapy/psychotherapy | 1 |
| 103 | physiobalneotherapy | 1 |
| 104 | posttrransplant | 1 |
| 105 | pravastotin | 1 |
| 106 | prp- | 1 |
| 107 | prp-insulin | 1 |
| 108 | psychotherapeutic-psychopharmacological | 1 |
| 109 | ptx-vit.e | 1 |
| 110 | regions/organizations | 1 |
| 111 | rgh-bp | 1 |
| 112 | semitendinosis | 1 |
| 113 | sglt-ivt | 1 |
| 114 | spinal-epidurals | 1 |
| 115 | studies.ximelagatran | 1 |
| 116 | tests-echocardiography | 1 |
| 117 | text-word | 1 |
| 118 | therapy-program | 1 |
| 119 | therapy.patients | 1 |
| 120 | tlr-activation | 1 |
| 121 | top/p | 1 |
| 122 | traditional-chinese-medicine- | 1 |
| 123 | ven-carbamazepine | 1 |
| 124 | venectomies | 1 |
| 125 | venectomy | 1 |
| 126 | withnasopore | 1 |
| 127 | y-splitting | 1 |
| 1 | 2-arylethynyl-n | 1 |
| 2 | 5-fluorouracil+adriamycin | 1 |
| 3 | abacavir-lamivudine-zidovudine | 13 |
| 4 | abnormalities-edema | 1 |
| 5 | abnormlities | 1 |
| 6 | aggressors | 9 |
| 7 | alpha/beta-blockade | 1 |
| 8 | alpha/beta-blocker | 1 |
| 9 | alpha1-beta-blockade | 1 |
| 10 | antibiotic/corticosteroid | 1 |
| 11 | antidepressant/psychotherapy | 1 |
| 12 | antimuscarinic+α-blocker | 1 |
| 13 | anxiolytic-antidepressant | 1 |
| 14 | arvs/ei-aeds | 1 |
| 15 | arvs/nei-aeds | 1 |
| 16 | asa-statin | 1 |
| 17 | at/rt/imt | 1 |
| 18 | benzodiazepines/antipsychotics | 1 |
| 19 | beta-blocker-diuretic | 1 |
| 20 | bsph/masters | 1 |
| 21 | c2-phenylethynyl | 1 |
| 22 | cbt-antidepressant | 1 |
| 23 | clearpath | 1 |
| 24 | cm-mtssg | 1 |
| 25 | cognitive/performance | 1 |
| 26 | counseling- | 1 |
| 27 | ct-pharmacotherapy | 1 |
| 28 | dc/ah | 2 |
| 29 | delignification-il | 1 |
| 30 | dexamethasone-suppression/crh-stimulation | 1 |
| 31 | dexmedetomidine/fentanyl | 2 |
| 32 | doxycycline-gentamicin | 1 |
| 33 | doxycycline/co-trimoxazole | 1 |
| 34 | ebrt/bt | 1 |
| 35 | ebus/eus | 4 |
| 36 | effects.amoxicillin | 1 |
| 37 | end-variables | 1 |
| 38 | eood | 1 |
| 39 | erosion/abrasion | 1 |
| 40 | estradiol-levonorgestrel | 2 |
| 41 | estrogen/progestogen- | 1 |
| 42 | exp/rp-dcs | 1 |
| 43 | findings-individually | 1 |
| 44 | flcκ+flcλ | 1 |
| 45 | flowcytobot | 1 |
| 46 | fluconazole/amphotericin-b | 1 |
| 47 | fluoride-laser | 1 |
| 48 | fluoxetine-tricyclic | 1 |
| 49 | fluoxetine/cbt | 4 |
| 50 | fnb-pi | 1 |
| 51 | fnb-snb | 1 |
| 52 | freeze- | 1 |
| 53 | fs/te | 3 |
| 54 | furosemide/spironolactone | 1 |
| 55 | g308a | 1 |
| 56 | gemfibrozil/diet | 1 |
| 57 | glizigen-viusid | 2 |
| 58 | heat-irradiation | 3 |
| 59 | heat/ultrasonication | 1 |
| 60 | hypercholesterolemia-hypertriglyceridemia | 2 |
| 61 | hypolipidaemia | 1 |
| 62 | i.v./i.a | 1 |
| 63 | icp/cpp- | 1 |
| 64 | intrasaccular | 1 |
| 65 | intravenous-intraperitoneal | 1 |
| 66 | irradiation-heat | 4 |
| 67 | laser-fluoride | 1 |
| 68 | laser/fluoride | 1 |
| 69 | latae | 15 |
| 70 | me-ketamine | 1 |
| 71 | measurement-förster | 1 |
| 72 | mesoscopic-network | 1 |
| 73 | metformin/pioglitazone | 1 |
| 74 | methotrexate/sulphasalazine/hydroxychlorquine | 1 |
| 75 | methylphenidate-quetiapine | 1 |
| 76 | methylphenidate/behavioural | 1 |
| 77 | mevinolin-neomycin | 1 |
| 78 | mgb1d-and | 1 |
| 79 | micromechanics | 1 |
| 80 | modalities | 3,768 |
| 81 | modalities-ultrasound | 1 |
| 82 | modality | 2,784 |
| 83 | modem-interface | 1 |
| 84 | naa-based | 1 |
| 85 | noradrenaline/serotonin | 1 |
| 86 | nrt/hp | 1 |
| 87 | oi/eds | 1 |
| 88 | p=2.4×10 | 1 |
| 89 | pacap6-38- | 1 |
| 90 | peer-expert | 1 |
| 91 | pentoxifylline-tocopherol | 2 |
| 92 | ph-potentiometric | 1 |
| 93 | pharmaco-psychotherapy | 1 |
| 94 | pharmacotherapy/psychotherapy | 1 |
| 95 | physiobalneotherapy | 1 |
| 96 | posttrransplant | 1 |
| 97 | ppc/pobh | 4 |
| 98 | pravastotin | 1 |
| 99 | progestogen-estrogen | 2 |
| 100 | prp- | 1 |
| 101 | prp-insulin | 1 |
| 102 | psycho-pharmacotherapy | 2 |
| 103 | psychotherapeutic-psychopharmacological | 1 |
| 104 | ptx-vit.e | 1 |
| 105 | regions/organizations | 1 |
| 106 | rgh-bp | 1 |
| 107 | seasonal-pandemic | 2 |
| 108 | semitendinosis | 1 |
| 109 | sglt-ivt | 1 |
| 110 | simulation- | 2 |
| 111 | spinal-epidurals | 1 |
| 112 | studies.ximelagatran | 1 |
| 113 | tests-echocardiography | 1 |
| 114 | text-word | 1 |
| 115 | therapy-program | 1 |
| 116 | therapy.patients | 1 |
| 117 | tlr-activation | 1 |
| 118 | top/p | 1 |
| 119 | trabeculotomy-trabeculectomy | 4 |
| 120 | traditional-chinese-medicine- | 1 |
| 121 | ultrasound-biochemistry | 3 |
| 122 | vasopressin-epinephrine | 2 |
| 123 | ven-carbamazepine | 1 |
| 124 | venectomies | 1 |
| 125 | venectomy | 1 |
| 126 | withnasopore | 1 |
| 127 | y-splitting | 1 |
| 1 | pacap6-38- | 1 |
| 2 | traditional-chinese-medicine- | 1 |
| 3 | freeze- | 1 |
| 4 | counseling- | 1 |
| 5 | estrogen/progestogen- | 1 |
| 6 | simulation- | 2 |
| 7 | icp/cpp- | 1 |
| 8 | prp- | 1 |
| 9 | p=2.4×10 | 1 |
| 10 | i.v./i.a | 1 |
| 11 | g308a | 1 |
| 12 | hypolipidaemia | 1 |
| 13 | hypercholesterolemia-hypertriglyceridemia | 2 |
| 14 | abnormalities-edema | 1 |
| 15 | fluconazole/amphotericin-b | 1 |
| 16 | fnb-snb | 1 |
| 17 | fluoxetine-tricyclic | 1 |
| 18 | seasonal-pandemic | 2 |
| 19 | ph-potentiometric | 1 |
| 20 | beta-blocker-diuretic | 1 |
| 21 | naa-based | 1 |
| 22 | antibiotic/corticosteroid | 1 |
| 23 | glizigen-viusid | 2 |
| 24 | mgb1d-and | 1 |
| 25 | modalities-ultrasound | 1 |
| 26 | eood | 1 |
| 27 | text-word | 1 |
| 28 | ptx-vit.e | 1 |
| 29 | latae | 15 |
| 30 | modem-interface | 1 |
| 31 | cognitive/performance | 1 |
| 32 | alpha1-beta-blockade | 1 |
| 33 | alpha/beta-blockade | 1 |
| 34 | laser-fluoride | 1 |
| 35 | laser/fluoride | 1 |
| 36 | doxycycline/co-trimoxazole | 1 |
| 37 | abacavir-lamivudine-zidovudine | 13 |
| 38 | me-ketamine | 1 |
| 39 | methylphenidate-quetiapine | 1 |
| 40 | ven-carbamazepine | 1 |
| 41 | vasopressin-epinephrine | 2 |
| 42 | methotrexate/sulphasalazine/hydroxychlorquine | 1 |
| 43 | furosemide/spironolactone | 1 |
| 44 | metformin/pioglitazone | 1 |
| 45 | withnasopore | 1 |
| 46 | fs/te | 3 |
| 47 | y-splitting | 1 |
| 48 | cm-mtssg | 1 |
| 49 | dc/ah | 2 |
| 50 | ppc/pobh | 4 |
| 51 | clearpath | 1 |
| 52 | fnb-pi | 1 |
| 53 | mesoscopic-network | 1 |
| 54 | psychotherapeutic-psychopharmacological | 1 |
| 55 | intravenous-intraperitoneal | 1 |
| 56 | methylphenidate/behavioural | 1 |
| 57 | estradiol-levonorgestrel | 2 |
| 58 | delignification-il | 1 |
| 59 | pentoxifylline-tocopherol | 2 |
| 60 | dexmedetomidine/fentanyl | 2 |
| 61 | c2-phenylethynyl | 1 |
| 62 | therapy-program | 1 |
| 63 | 2-arylethynyl-n | 1 |
| 64 | studies.ximelagatran | 1 |
| 65 | progestogen-estrogen | 2 |
| 66 | doxycycline-gentamicin | 1 |
| 67 | 5-fluorouracil+adriamycin | 1 |
| 68 | mevinolin-neomycin | 1 |
| 69 | effects.amoxicillin | 1 |
| 70 | prp-insulin | 1 |
| 71 | noradrenaline/serotonin | 1 |
| 72 | asa-statin | 1 |
| 73 | pravastotin | 1 |
| 74 | erosion/abrasion | 1 |
| 75 | heat/ultrasonication | 1 |
| 76 | heat-irradiation | 3 |
| 77 | dexamethasone-suppression/crh-stimulation | 1 |
| 78 | tlr-activation | 1 |
| 79 | top/p | 1 |
| 80 | rgh-bp | 1 |
| 81 | nrt/hp | 1 |
| 82 | intrasaccular | 1 |
| 83 | alpha/beta-blocker | 1 |
| 84 | antimuscarinic+α-blocker | 1 |
| 85 | fluoride-laser | 1 |
| 86 | measurement-förster | 1 |
| 87 | exp/rp-dcs | 1 |
| 88 | micromechanics | 1 |
| 89 | benzodiazepines/antipsychotics | 1 |
| 90 | oi/eds | 1 |
| 91 | arvs/ei-aeds | 1 |
| 92 | arvs/nei-aeds | 1 |
| 93 | venectomies | 1 |
| 94 | modalities | 3,768 |
| 95 | abnormlities | 1 |
| 96 | end-variables | 1 |
| 97 | semitendinosis | 1 |
| 98 | spinal-epidurals | 1 |
| 99 | regions/organizations | 1 |
| 100 | bsph/masters | 1 |
| 101 | aggressors | 9 |
| 102 | therapy.patients | 1 |
| 103 | ebus/eus | 4 |
| 104 | irradiation-heat | 4 |
| 105 | ebrt/bt | 1 |
| 106 | fluoxetine/cbt | 4 |
| 107 | gemfibrozil/diet | 1 |
| 108 | at/rt/imt | 1 |
| 109 | posttrransplant | 1 |
| 110 | anxiolytic-antidepressant | 1 |
| 111 | cbt-antidepressant | 1 |
| 112 | flowcytobot | 1 |
| 113 | peer-expert | 1 |
| 114 | sglt-ivt | 1 |
| 115 | tests-echocardiography | 1 |
| 116 | findings-individually | 1 |
| 117 | trabeculotomy-trabeculectomy | 4 |
| 118 | venectomy | 1 |
| 119 | psycho-pharmacotherapy | 2 |
| 120 | ct-pharmacotherapy | 1 |
| 121 | physiobalneotherapy | 1 |
| 122 | pharmaco-psychotherapy | 1 |
| 123 | antidepressant/psychotherapy | 1 |
| 124 | pharmacotherapy/psychotherapy | 1 |
| 125 | ultrasound-biochemistry | 3 |
| 126 | modality | 2,784 |
| 127 | flcκ+flcλ | 1 |